Carisma Therapeutics Inc. Quarterly Operating Lease, Liability in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Carisma Therapeutics Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2018 to Q3 2024.
  • Carisma Therapeutics Inc. Operating Lease, Liability for the quarter ending September 30, 2024 was $2.15M, a 22.9% increase year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.15M +$400K +22.9% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.97M -$1.43M -42% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.23M +$1.69M +47.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.25M Dec 31, 2023 10-K 2024-04-01
Q3 2023 $1.75M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.41M Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.55M Mar 31, 2023 10-Q 2023-05-11
Q4 2021 $124K -$147K -54.2% Dec 31, 2021 10-K 2022-02-28
Q4 2020 $271K +$159K +142% Dec 31, 2020 10-K 2021-03-15
Q4 2019 $112K -$88K -44% Dec 31, 2019 10-K 2020-03-16
Q3 2019 $145K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $180K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $211K Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $200K Jan 1, 2019 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.